Digital learning expansion Medtelligence launched a digital learning platform in March 2019, indicating willingness to scale through online CME delivery. This presents an opportunity to pitch expanded digital education partnerships, platform enhancements, or multilingual content to broaden reach.

Therapeutic breadth Strong focus across cardiovascular, endocrinology, dermatology, pain management, and neurology suggests potential cross-sell to pharma sponsors with assets in these areas and opportunities to co-create CME activities aligned with portfolio strategies.

US market positioning As a member of US HealthConnect and operating in the CME space, Medtelligence can leverage industry relationships for sponsored content, speaker programs, and data-driven education initiatives that align with pharmaceutical marketing and physician engagement goals.

Growth signals Revenue range of one to ten million alongside a lean headcount (2-10 employees) implies agility and potential scalability through partner integrations, automation, and expanded client acquisition efforts, particularly with mid-market sponsors.

Tech stack leverage Use of Salesforce, Marketo, Mailchimp, OneTrust, Piwik PRO Core and ad platforms indicates capability for robust demand generation, data privacy compliance, and analytics-driven targeting—areas to highlight in conversations about program optimization and measurable ROI.